Search research articles
Contact Us
Filters
Showing results (1-10 of 262) with videos related to
Page
of 27
Sort By:
The Lancet. Child & Adolescent Health
|
August 8, 2020
Finding a path to reopen schools during the COVID-19 pandemic
W John Edmunds
European Journal of Epidemiology
|
June 8, 2004
The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses
Alessia Melegaro, W John Edmunds
The Journal of Infectious Diseases
|
May 2, 2003
Future savings from measles eradication in industrialized countries
Hélène Carabin, W John Edmunds
BMC Medicine
|
March 13, 2020
Childhood vaccination against seasonal influenza - is there a risk of undesirable outcomes?
Marc Baguelin, W John Edmunds
The Lancet. Infectious Diseases
|
December 11, 2020
The role of schools and school-aged children in SARS-CoV-2 transmission
Stefan Flasche, W John Edmunds
European Journal of Epidemiology
|
June 8, 2004
The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales
Alessia Melegaro, W John Edmunds
Expert Review of Vaccines
|
November 16, 2012
Using the internet to estimate influenza vaccine effectiveness
W John Edmunds, Sebastian Funk
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
February 24, 2006
Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model
Caroline L Trotter, W John Edmunds
BMJ (Clinical Research Ed.)
|
April 6, 2002
Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales
Caroline L Trotter, W John Edmunds
Lancet (London, England)
|
September 28, 2014
Case fatality rate for Ebola virus disease in west Africa
Adam J Kucharski, W John Edmunds
Page
of 27
Search research articles
Search
Showing results (1-10 of 262) with videos related to
Sort By:
Page
of 27
The Lancet. Child & Adolescent Health
|
August 8, 2020
Finding a path to reopen schools during the COVID-19 pandemic
W John Edmunds
European Journal of Epidemiology
|
June 8, 2004
The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses
Alessia Melegaro, W John Edmunds
The Journal of Infectious Diseases
|
May 2, 2003
Future savings from measles eradication in industrialized countries
Hélène Carabin, W John Edmunds
BMC Medicine
|
March 13, 2020
Childhood vaccination against seasonal influenza - is there a risk of undesirable outcomes?
Marc Baguelin, W John Edmunds
The Lancet. Infectious Diseases
|
December 11, 2020
The role of schools and school-aged children in SARS-CoV-2 transmission
Stefan Flasche, W John Edmunds
European Journal of Epidemiology
|
June 8, 2004
The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales
Alessia Melegaro, W John Edmunds
Expert Review of Vaccines
|
November 16, 2012
Using the internet to estimate influenza vaccine effectiveness
W John Edmunds, Sebastian Funk
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
February 24, 2006
Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model
Caroline L Trotter, W John Edmunds
BMJ (Clinical Research Ed.)
|
April 6, 2002
Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales
Caroline L Trotter, W John Edmunds
Lancet (London, England)
|
September 28, 2014
Case fatality rate for Ebola virus disease in west Africa
Adam J Kucharski, W John Edmunds
Page
of 27